Understanding how the thymus prevents autoimmune diseases
Thymic medullary epithelial cell turnover and control of immune tolerance
This work explores how a special part of the immune system, called the thymus, teaches immune cells to recognize and protect your own body, helping to prevent conditions like Type 1 diabetes and multiple sclerosis.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11126878 on NIH RePORTER |
What this research studies
Our immune system needs to be strong enough to fight off germs but also smart enough not to attack our own body. The thymus gland plays a crucial role in training immune cells, called T cells, to tell the difference between foreign invaders and our own healthy tissues. This project focuses on a key gene called Aire, which helps the thymus remove T cells that might mistakenly attack the body, leading to autoimmune diseases. We are looking at newly discovered cells in the thymus that also help with this training, using advanced genetic tools and mouse models to understand their specific roles.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but future studies building on this work might seek individuals with autoimmune conditions or those at risk.
Not a fit: Patients not interested in the basic science of immune system function or those without autoimmune conditions may not find direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat autoimmune diseases by improving how the immune system learns to tolerate the body's own tissues.
How similar studies have performed: Research into the Aire gene has already shown its critical role in human autoimmune syndromes, indicating that understanding these mechanisms is a promising area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Anderson, Mark S — University of California, San Francisco
- Study coordinator: Anderson, Mark S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.